Online medical weight management, built around you
VelaHealth & Wellness
Begin your intake
Treatment library

Understand the options. Then make a decision.

Clear, practical education on four Vela treatment topics: what they are, how they work, and where provider judgment matters.

Start here

Weight-management medication and broader wellness options are not the same thing.

Semaglutide and tirzepatide are prescription medication pathways used in chronic weight care. NAD+ and sermorelin are separate wellness topics with different evidence, uses, and clinical considerations.

Prescription

Prescription weight-management medications

Provider-guided options used in chronic weight care.

Semaglutide

GLP-1 medication

Established GLP-1 care with a substantial clinical evidence base.

Semaglutide is the active ingredient in several prescription medicines. In weight care, it works with the body’s appetite signals and may help eligible patients eat less while building sustainable nutrition and activity habits.

Potential place in care

  • A widely recognized option with extensive weight-management research
  • Supports reduced appetite and calorie intake
  • Designed for long-term weight management when prescribed appropriately
Read the clinical brief

Tirzepatide

GIP + GLP-1 medication

A highly effective dual-pathway option for provider-guided weight care.

Tirzepatide works with both GIP and GLP-1 receptors. In weight care, this dual action can support appetite regulation, reduced food intake, and long-term weight management when paired with a provider-led plan.

Potential place in care

  • Supports appetite regulation through two hormone pathways
  • Demonstrated substantial average weight reduction in large clinical trials of branded tirzepatide
  • Designed for chronic weight management in eligible adults
Read the clinical brief
Wellness

Separate wellness topics

Options with different intended uses, evidence, and clinical considerations.

NAD+

Wellness option

A cellular-wellness conversation grounded in biology, not anti-aging promises.

Nicotinamide adenine dinucleotide, shortened to NAD+, is present in living cells and participates in reactions that help convert nutrients into usable cellular energy. Vela presents it as a separate wellness topic, not as a replacement for medical weight-management treatment.

Potential place in care

  • An important molecule in normal cellular energy pathways
  • Can be discussed as part of a broader wellness conversation
  • Considered separately from prescription weight-management medication
Read the clinical brief

Sermorelin

Hormone-pathway option

An individualized hormone-pathway conversation, not a shortcut or a substitute for weight care.

Sermorelin is a synthetic analogue of growth-hormone-releasing hormone. It signals the pituitary gland to release growth hormone. Because this is a distinct hormone pathway, any discussion should begin with careful evaluation rather than broad wellness promises.

Potential place in care

  • A well-defined hormone-signaling mechanism
  • Can be evaluated in an individualized clinical context
  • Considered separately from prescription weight-management medication
Read the clinical brief
Next step

You do not need to choose alone.

Share your history, goals, and questions. A licensed provider can help determine which options deserve a closer look.

Start your review